尼姆叶糖蛋白破坏耗尽的CD8+T细胞介导的癌症干细胞侵略性
Mohona Chakravarti1, Saurav Bera1, Sukanya Dhar1
1Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute (CNCI), Kolkata, India.
Molecular cancer research : MCR
|May 14, 2024
概括
尼姆叶糖蛋白 (NLGP) 免疫疗法有效地向由耗尽的CD8+T细胞 (TEX) 加重的癌症干细胞 (CSCs). NLGP重新编程CSC,使它们对化疗敏感,并保护它们免受毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耗尽的CD8+T细胞 (TEX) 会加剧癌症干细胞 (CSC) 的毒性,从而构成治疗挑战.
- 尼姆叶糖蛋白 (NLGP) 是一种来自植物的免疫调节剂,已经显示出免疫依赖的瘤限制.
- 对于NLGP对TEX进行重编程以针对CSC的潜力,需要进行调查.
研究的目的:
- 调查NLGP免疫疗法在向TEX诱导的CSC中的有效性.
- 阐明NLGP影响CSC和TEX的机制.
- 评估NLGP与化疗结合的治疗潜力.
主要方法:
- 使用了体内B16-F10黑色素瘤模型和体内TEX/CSC共同培养系统.
- 评估了NLGP治疗对CSC克隆原性,耐药性和关键标志物 (PDL1,OCT4,SOX2) 的影响.
- 进行了细胞循环分析,西部涂抹和Dectin-1,Notch1和mTOR通路调查.
主要成果:
- 在体内和体外,NLGP的使用显著降低了CSC的毒性.
- 在NLGP下调中,CSC的克隆原性,多药耐药性,PDL1,OCT4和SOX2.
- 经过NLGP培养的TEX诱导CSC进入S相,增强对5-甲 (5FU) 的敏感性并显示脏保护.
结论:
- NLGP免疫疗法有效地缓解了TEX诱导的CSC恶化.
- NLGP重新编程CSC,增加它们对化疗的敏感性,并减轻5FU的毒性.
- 德-1介导的NLGP作用突出了针对T细胞耗尽的新型免疫治疗点.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cytotoxic T Cells-mediated Immune Response
901
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
901
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Cells of the Innate Immune Response
1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K


